4th Annual Advances in Immuno-Oncology UK Congress

We are happy to announce that our team will be attending the 4th Annual Advances in Immuno-Oncology UK Congress to be held in London, 20 - 21 May 2019.

Our team on-site:
-    Christine Duthoit, in vivo Engineering Manager
-    Marlayna Sterner, Sales Engineer

Our team will also present a poster:

"Primary cells and in vivo immunomodulation using LentiFlash®, a chimeric RNA delivery technology designed for clinical applications"

Do not hesitate to contact us at sales@flashtherapeutics.com to schedule a meeting with our team before the event.

Main immune-oncologic themes of the event:
•    Discovery of Immuno-Oncology Therapies
•    Preclinical Development
•    Translational Immuno-Oncology
•    Precision Medicine and Personalised Therapy
•    Genomics in Cancer Immunotherapy
•    Immuno-Oncology Clinical Research and Clinical Trials

The 4th Annual Advances in Immuno-Oncology UK Congress has been created to give a comprehensive look at immuno-oncology drug development from early discovery to clinical applications, featuring key therapeutic strategies such as T-cell therapies, adoptive cell transfer, checkpoint inhibitors and oncolytic viral therapies. Benefit further from case studies on the delivery of personalized immuno-therapy and genomic approaches, as well as formulation and CMC considerations.

To learn more about this event please click here.

by Yohann Moal